AMHD — HLK Biotec Holding Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.41m
Annual income statement for HLK Biotec Holding, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
1998 June 30th | 1999 June 30th | |
|---|---|---|
| Period Length: | 1 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG |
| Status: | Final | Final |
| Total Revenue | 0 | 0 |
| Selling / General / Administrative Expenses | ||
| Depreciation and Amortization | ||
| Other Operating Expenses | ||
| Total Operating Expenses | 0.08 | 0.707 |
| Operating Profit | -0.08 | -0.707 |
| Total Net Non Operating Interest Income / Expense | ||
| Other Net Non Operating Costs | ||
| Net Income Before Taxes | -0.08 | -1.04 |
| Provision for Income Taxes | ||
| Net Income After Taxes | -0.08 | -1.04 |
| Net Income Before Extraordinary Items | ||
| Net Income | -0.08 | -1.04 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||
| Income Available to Common Shareholders Including Extraordinary Items | ||
| Dilution Adjustment | ||
| Diluted Net Income | -0.08 | -1.04 |
| Diluted Weighted Average Shares | ||
| Basic EPS Including Extraordinary Items | ||
| Diluted EPS Including Extraordinary Items | ||
| Diluted EPS Excluding Extraordinary Items | ||
| Normalised Income Before Taxes | ||
| Normalised Income After Taxes | ||
| Normalised Income Available to Common Shareholders | ||
| Diluted Normalised EPS | -2,000,000 | -25,516,224 |
| Dividends per Share |